L. Dubois

Pharmacodynamic Markers of LRRK2 Inhibition in Biofluids

J. Brotchie, N. Schussler, S. Boularand, 2020, bioRxiv.

Mitochondrial DNA damage as a potential biomarker of LRRK2 kinase activity in LRRK2 Parkinson’s disease

S. Boularand, L. Sanders, C. Gonzalez-Hunt, 2020, Scientific Reports.